H. Kühnle

831 total citations
35 papers, 573 citations indexed

About

H. Kühnle is a scholar working on Oncology, Epidemiology and Reproductive Medicine. According to data from OpenAlex, H. Kühnle has authored 35 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Epidemiology and 11 papers in Reproductive Medicine. Recurrent topics in H. Kühnle's work include Ovarian cancer diagnosis and treatment (11 papers), Cancer Treatment and Pharmacology (9 papers) and Cervical Cancer and HPV Research (6 papers). H. Kühnle is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Cancer Treatment and Pharmacology (9 papers) and Cervical Cancer and HPV Research (6 papers). H. Kühnle collaborates with scholars based in Germany. H. Kühnle's co-authors include Karl Ulrich Petry, Michael Glaubitz, Oliver Brummer, Gerd Böhmer, Ulrike Bode, I. Schedel, Heinrich G. Köchel, S Niesert, E. Kupsch and Bettina Hollwitz and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and International Journal of Cancer.

In The Last Decade

H. Kühnle

33 papers receiving 542 citations

Peers

H. Kühnle
Nine van der Vange Netherlands
R. J. Kurman United States
K Nasiell Sweden
P. Wilson United Kingdom
John P. Koulos United States
Jan Pyman Australia
H. Kühnle
Citations per year, relative to H. Kühnle H. Kühnle (= 1×) peers Wenche Reed

Countries citing papers authored by H. Kühnle

Since Specialization
Citations

This map shows the geographic impact of H. Kühnle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kühnle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kühnle more than expected).

Fields of papers citing papers by H. Kühnle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kühnle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kühnle. The network helps show where H. Kühnle may publish in the future.

Co-authorship network of co-authors of H. Kühnle

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kühnle. A scholar is included among the top collaborators of H. Kühnle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kühnle. H. Kühnle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brummer, Oliver, Bettina Hollwitz, Gerd Böhmer, H. Kühnle, & Karl Ulrich Petry. (2006). Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecologic Oncology. 102(3). 517–522. 29 indexed citations
2.
Liebrich, Clemens, et al.. (2006). Plattenepithelkarzinom der Neovagina nach Mayer-Rokitansky-Küster-Hauser-Syndrom. Zentralblatt für Gynäkologie. 128(5). 271–274. 7 indexed citations
3.
Brummer, Oliver, H.-E. Stegner, Gerd Böhmer, H. Kühnle, & Karl Ulrich Petry. (2004). HER-2/neu expression in Paget disease of the vulva and the female breast. Gynecologic Oncology. 95(2). 336–340. 36 indexed citations
4.
Böhmer, Gerd, Karl Ulrich Petry, Thomas Iftner, et al.. (2002). Detection of Human Papillomavirus DNA Using Hybrid Capture Does Not Allow Sufficient Triaging of Recurrent Atypical Pap Smear Classified as Pap III D. Zentralblatt für Gynäkologie. 124(2). 111–115. 3 indexed citations
6.
Brummer, Oliver, Gerd Böhmer, Bettina Hollwitz, et al.. (2002). MMP-1 and MMP-2 in the Cervix Uteri in Different Steps of Malignant Transformation—An Immunohistochemical Study. Gynecologic Oncology. 84(2). 222–227. 55 indexed citations
7.
Kühnle, H., et al.. (2001). Nachsorge inklusive Hormonsubstitutionstherapie. Der Gynäkologe. 34(11). 1058–1064.
8.
Scholz, Ursula, et al.. (2000). A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.. PubMed. 14(10 Suppl 9). 44–6. 3 indexed citations
9.
Meerpohl, H. G., Willi Sauerbrei, H. Kühnle, Martin Schumacher, & A. Pfleiderer. (1997). Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease. Gynecologic Oncology. 66(1). 75–84. 19 indexed citations
10.
Glaubitz, Michael, et al.. (1997). Phase I study of weekly docetaxel (Taxotere®) in heavily pretreated breast cancer patients. European Journal of Cancer. 33. S158–S158. 28 indexed citations
11.
Glaubitz, Michael, et al.. (1996). Die elektrochirurgische Schlingenexzision der Transformationszone (LEEP) zur Behandlung zervikaler Neoplasien. Geburtshilfe und Frauenheilkunde. 56(10). 513–516. 3 indexed citations
12.
Petry, Karl Ulrich, Heinrich G. Köchel, Ulrike Bode, et al.. (1996). Human Papillomavirus Is Associated with the Frequent Detection of Warty and Basaloid High-Grade Neoplasia of the Vulva and Cervical Neoplasia among Immunocompromised Women. Gynecologic Oncology. 60(1). 30–34. 46 indexed citations
13.
Petry, Karl Ulrich, Ulrike Bode, Heinrich G. Köchel, et al.. (1994). Cellular immunodeficiency enhances the progression of human papillomavirus‐associated cervical lesions. International Journal of Cancer. 57(6). 836–840. 197 indexed citations
14.
Dieterle, Stefan, et al.. (1991). „Glassy cell Carcinoma“ der Zervix. Geburtshilfe und Frauenheilkunde. 51(6). 484–485. 2 indexed citations
15.
Osmers, R., B. Hinney, H. Kühnle, et al.. (1990). Klinisches Management von zystischen Ovarialtumoren. Geburtshilfe und Frauenheilkunde. 50(1). 20–28. 2 indexed citations
16.
Kühnle, H. & J. Hilfrich. (1985). Chemotherapie des fortgeschrittenen Ovarialkarzinoms. Oncology Research and Treatment. 8(6). 374–382. 3 indexed citations
17.
Rath, Werner, et al.. (1982). Changes in collagen content of the first trimester cervix uteri after treatment with prostaglandin F2α gel. Archives of Gynecology and Obstetrics. 231(2). 107–110. 10 indexed citations
19.
Rath, Werner, et al.. (1982). Objective demonstration of cervical softening with a prostaglandin F2α gel during first trimester abortion. International Journal of Gynecology & Obstetrics. 20(3). 195–199. 8 indexed citations
20.
Ulbrich, R. G., et al.. (1979). [Light and electron microscopical studies of cervix following local administration of prostaglandin gel (PGF2alpha)].. PubMed. 228(1-4). 417–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026